Shichen Q. Xu
NHC Key Laboratory Of Nuclear Medicine, Jiangsu Key Laboratory Of Molecular Nuclear Medicine
China
China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Post-therapy radioiodine imaging characterizes occult metastatic differentiated thyroid carcinoma years after thyroidectomy for presumed benign multinodular goiter.
Journal: Seminars in nuclear medicine
Published: May 28, 2026
Loss of CSE couples with BRAF V600E to fuel thyroid cancer metastatic progression through zinc-dependent activation of the EMT machinery.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 16, 2026
From Uptake Restoration to Clinical Actionability: Toward Dosimetry-Defined Short-Course Redifferentiation in RAIR Thyroid Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 13, 2026
Inhibition of TGF-β1/Smad signaling reverses the dedifferentiated phenotype of thyroid cancer cells in three-dimensional culture.
Journal: Journal of endocrinological investigation
Published: January 08, 2026
Clinical outcome and prognosis of differentiated thyroid carcinoma with distant metastasis.
Journal: Nuclear medicine communications
Published: February 27, 2025
Influence of Body Mass Index on the Clinicopathological Features of Papillary Thyroid Carcinoma in a Chinese Population.
Journal: Metabolic syndrome and related disorders
Published: January 09, 2025
Lomibuvir sensitizes radioiodine-resistant thyroid cancer cell lines to radioiodine treatment by targeting hTERT RNA-dependent polymerase activity.
Journal: Journal of endocrinological investigation
Published: December 08, 2024
Preoperative Serum Thyroglobulin Levels Predict Radioiodine Therapy Outcome in Papillary Thyroid Microcarcinoma Patients.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: March 19, 2024
Risk-stratified Distant Metastatic Thyroid Cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: November 03, 2023
A Combination of BRAF and EZH1/SPOP/ZNF148 Three-Gene Mutational Classifier Improves Benign Call Rate in Indeterminate Thyroid Nodules.
Journal: Endocrine pathology
Published: August 05, 2023
Last Updated: 09/26/2026